fda statement on compounded semaglutide The should require negative studies of a new drug to be included in the product's labeling, concluded researchers who examined the nearly decades-long journey of rejections that led up to the Compounded GLP-1s: Why doctors worry

Free Educational Webinar: GLP-1s and the Psychology of Eating: Implications for Eating Disorder Recovery Thursday, January 29, 2026 Noon Mountain Time GLP-1s and the Psychology of Eating: Implications for Eating Disorder Recovery Danielle Rhodes, MS, RD, LD Center for Change Boise Program Director (Please note that this webinar was originally presented on January 22, but due to technical issues, we added another webinar) Register here Post-test For reference only About the Presenter: Danielle Rhodes, MS, RD, LD is a dedicated Program Director and dietitian based in Boise, Idaho

"I have the sex drive of a 17-year-old again

10.1016/j.metabol.2010.03.010 56

Frequently Asked Questions What counts as microdosing Ozempic or Wegovy

At Perfect B, Fitzpatrick assessment is part of every pre-treatment evaluation and shapes the entire session protocol